Skip to content

H.R. 1796 · 119th Congress (2025–2027)

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve prevention and treatment of sickle cell disease and complications from the disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Show official title

To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1796’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. John James (R-MI-10)
Cosponsors
6 cosponsors

4 original · 2 later

1 R · 5 D

  1. Rep. Troy A. Carter (D-LA-2)· Original · Mar 3, 2025
  2. Rep. Danny K. Davis (D-IL-7)· Original · Mar 3, 2025
  3. Rep. Jennifer A. Kiggans (R-VA-2)· Original · Mar 3, 2025
  4. Rep. Marc A. Veasey (D-TX-33)· Original · Mar 3, 2025
  5. Rep. Eugene Simon Vindman (D-VA-7)· Later · Aug 15, 2025
  6. Rep. Sanford D. Bishop, Jr. (D-GA-2)· Later · Jan 16, 2026
Policy area
Health
Subjects
  • Blood and blood diseases
  • Genetics
  • Health promotion and preventive care
  • Hereditary and development disorders
  • Medical research
  • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Mar 3, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

    Display title, Short title · Introduced in House

  2. To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.

    Official title · Introduced in House